FDA Inspection 1068227 — Giuseppe Plazzi, M.D.
The FDA completed an inspection of Giuseppe Plazzi, M.D. on September 20, 2018 in Bologna. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bologna (Italy)
Additional Details
Clinical Investigator (CI)